Your browser doesn't support javascript.
loading
Developing a web-based oncofertility tool for reproductive-age women with breast cancer based on social support framework.
Huang, Sheng-Miauh; Tseng, Ling-Ming; Yang, Ming-Jeng; Chang, Aria; Lien, Pei-Ju; Hsiung, Yvonne.
Afiliação
  • Huang SM; Department of Nursing, Mackay Medical College, No. 46, Section 3, Zhongzheng Road, New Taipei City 252, Sanzhi District, Taiwan. r910862@yahoo.com.tw.
  • Tseng LM; Department of Surgery, Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Yang MJ; School of Medicine, National Yang Ming Chiao Tung University, Taipei, 112, Taiwan.
  • Chang A; Institute of Geriatric Welfare Technology & Science, Mackay Medical College, New Taipei City, Taiwan.
  • Lien PJ; Institute of Geriatric Welfare Technology & Science, Mackay Medical College, New Taipei City, Taiwan.
  • Hsiung Y; Department of Surgery, Comprehensive Breast Health Center, Taipei Veterans General Hospital, Taipei, Taiwan.
Support Care Cancer ; 30(7): 6195-6204, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35438338
PURPOSE: To develop electronic systems for oncofertility support, and to examine the comprehensibility, feasibility, usability, and effects on social support and preparation for decision-making. METHODS: The study steps were guided, tested, and utilized to (a) identify the requirements of a patient, (b) guide the development of support interventions, and (c) evaluate the quality of web-based oncofertility support. Alpha testing and beta testing were used to ensure the quality of the web-based oncofertility support tool. The effectiveness was evaluated using the Preparation for Decision-Making Scale and Social Support Questionnaire. RESULTS: At the alpha testing phase, the mean (± standard deviation) values of the comprehensibility and usability for reproductive-age women with breast cancer were 4.24 (± 0.47) and 4.42 (± 0.57); and the mean values of the acceptability and usability for healthcare providers were 4.04 (± 0.67) and 3.99 (± 0.66), respectively. At the beta testing phase, the mean values of the feasibility for patients and healthcare providers were 3.93 (± 0.67) and 4.17 (± 0.78), respectively. The corresponding mean Preparation for Decision-Making Scale scores were 3.78 ± 0.82 and 4.11 ± 0.93, respectively. The results of the Wilcoxon signed-rank test revealed that the informational and instrumental support scores improved significantly compared with the pre-test data (informational support: 8.94 ± 3.28 vs. 10.06 ± 1.91, p < 0.01; instrumental support: 7.44 ± 2.90 vs. 8.75 ± 2.57, p < 0.01). CONCLUSIONS: The oncofertility support website demonstrated acceptable comprehensibility, feasibility, and usability, in addition to informational and instrumental support. TRIAL REGISTRATION: Clinicaltrials.gov NCT05100498, https://clinicaltrials.gov/ct2/show/NCT05100498.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Preservação da Fertilidade Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Preservação da Fertilidade Tipo de estudo: Prognostic_studies / Qualitative_research Limite: Female / Humans Idioma: En Revista: Support Care Cancer Assunto da revista: NEOPLASIAS / SERVICOS DE SAUDE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan